Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
601
-
602
-
603
Association between Metabolic Syndrome and Decreased eGFR.
Published 2015“…</p><p>Association between Metabolic Syndrome and Decreased eGFR.</p>…”
-
604
-
605
MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM.
Published 2013“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
-
606
-
607
-
608
-
609
-
610
-
611
-
612
-
613
-
614
Decreased proliferation in <i>Csf1r<sup>−/−</sup></i> and <i>Csf1<sup>op/op</sup></i> mouse colonic epithelium.
Published 2013“…Bar = 50 µm. Means are depicted by horizontal bars, n = 3 per group, *<b>*</b>P<0.01, *P<0.05, using unpaired two-tailed t-test. …”
-
615
-
616
-
617
-
618
NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways.
Published 2020“…(J) A proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways through inversely modulating the levels of positive and negative pathway components is shown. Drk/Grb2 and MAPK, two positive components of the EGFR signaling pathway are targeted for degradation by the Arg/N-end rule pathway and E3 ubiquitin ligase Ubr4 while PP2AC, a negative regulator of EGFR signaling pathway, is targeted for degradation by the Ac/N-end rule pathway E3 ubiquitin ligase Cnot4. …”
-
619
-
620